Parkinson's Disease Tulip


advertisement
 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 03-14-2008, 05:08 PM #1
lou_lou's Avatar
lou_lou lou_lou is offline
In Remembrance
 
Join Date: Sep 2006
Location: about 45 minutes to anywhere!
Posts: 3,086
15 yr Member
lou_lou lou_lou is offline
In Remembrance
lou_lou's Avatar
 
Join Date: Sep 2006
Location: about 45 minutes to anywhere!
Posts: 3,086
15 yr Member
Question 10 Tips to Consider when Planning for Accountability, Reconciliation and Destruction

10 Tips to Consider when Planning for Accountability, Reconciliation and Destruction of Clinical Trial Material

http://static.fiercemarkets.com/publ...c/DAR_tips.pdf

Monica English* and Amy Ma, PhD
Introduction

All experimental compounds tested in humans during clinical development are under stringent control to ensure that these drugs are administered only to eligible patients participating in approved study protocols. To that end, regulatory agencies worldwide mandate that all investigational products manufactured for clinical trials must have cradle-to-grave tracking for accountability, reconciliation, and destruction.
The lifecycle of investigational product (IP) is complex, transitioning from a manufacturing environment during production to a clinical environment during experimentation. Each of these situations has a unique body of governing regulations, Good Manufacturing Practice (GMP) or Good Clinical Practice (GCP), respectively. Additionally, IP reverts back to GMP when accounted, reconciled, stored, and packed for destruction as waste, creating an additional transfer between these environments. It is critical that you be able to document and demonstrate to regulatory authorities that you are in complete control of the drug supply chain at all times and can account for the whereabouts of all manufactured investigational product, whether consumed or destroyed.

Currently the administrative burden of accounting for and reconciling clinical supplies rests largely on the investigative sites, monitors, and depots who generally perform these tasks manually and without the benefit of a central tool that tracks clinical material from manufacture to dispensation and return [1]. You can reduce this burden and streamline the process by considering and implementing these 10 easy tips, that will ultimately save money, minimize errors, and more efficiently reconcile all IP at study closeout per regulatory requirements.
__________________
with much love,
lou_lou


.


.
by
.
, on Flickr
pd documentary - part 2 and 3

.


.


Resolve to be tender with the young, compassionate with the aged, sympathetic with the striving, and tolerant with the weak and the wrong. Sometime in your life you will have been all of these.
lou_lou is offline   Reply With QuoteReply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Tips for planning vacations for the disabled BobbyB ALS 0 07-29-2007 07:46 AM
Easter Sunday means Resurrection Restoration and Reconciliation! Chemar Sanctuary for Spiritual Support 2 04-09-2007 08:14 PM
Vegetables of Mass Destruction ConsiderThis General Health Conditions & Rare Disorders 14 09-23-2006 04:37 PM


All times are GMT -5. The time now is 10:16 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.